Literature DB >> 15566108

Appropriate use of the carbapenems.

A J Brink1, C Feldman, D C Grolman, D Muckart, J Pretorius, G A Richards, M Senekal, W Sieling.   

Abstract

The carbapenems are a group of broad-spectrum beta-lactam antibiotic agents of which there are three parenteral preparations currently available in South Africa, namely imimpenem/cilastatin, meropenem and ertapenem. Owing to the fact that imipenem/cilastatin and meropenem have a broad spectrum of activity that includes Pseudomonas and Acinetobacter species, they are ideal antibiotics for treatment of severe nosocomial infections. In contrast, ertapenem has limited in vitro activity against the latter non-fermentative gram-negative bacteria and is therefore more suitable for the treatment of certain severe community-acquired infections. This statement arises out of concerns about the general abuse of antibiotics such as the carbapenems, with the primary intention of highlighting the appropriate use of these agents.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15566108

Source DB:  PubMed          Journal:  S Afr Med J


  3 in total

1.  CARBapenem utilizatiON evaluation in a large community hospital (CARBON): A Quality Improvement Study.

Authors:  Jesse Janssen; Angus Kinkade; Damen Man
Journal:  Can J Hosp Pharm       Date:  2015 Jul-Aug

2.  High prevalence of KPC-2-type carbapenemase coupled with CTX-M-type extended-spectrum beta-lactamases in carbapenem-resistant Klebsiella pneumoniae in a teaching hospital in China.

Authors:  Shudan Chen; Fupin Hu; Xiaogang Xu; Yang Liu; Weihong Wu; Demei Zhu; Honghai Wang
Journal:  Antimicrob Agents Chemother       Date:  2011-02-14       Impact factor: 5.191

Review 3.  OXA β-lactamases.

Authors:  Benjamin A Evans; Sebastian G B Amyes
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.